Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review
RSC Advances · 2026 · 16 (35) · 34023-34064
DOI: 10.1039/d6ra03227c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von K Nagaraj Pai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Manipal Institute of Technology, Manipal Academy of Higher Education Manipal-576104 India subrahmanya.bhat@manipal.edu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Synthesis of hydrazone derivatives and anticancer activities of quinoline-, indole-, triazole-, benzimidazole- and isatin-based hydrazone derivatives.
Autor:innen und Institutionen
- Manipal Institute of Technology, Manipal Academy of Higher Education Manipal-576104 India subrahmanya.bhat@manipal.edu.
ORCID-Profile: K Subrahmanya Bhat
Zitieren
APA
Pai, K. N., & Bhat, K. S. (2026). Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review. RSC Advances, 16(35), 34023-34064. https://doi.org/10.1039/d6ra03227c
Vancouver
Pai KN, Bhat KS. Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review. RSC Advances. 2026;16(35):34023-34064. doi:10.1039/d6ra03227c
BibTeX
@article{Pai2026,
author = {Pai, K Nagaraj and Bhat, K Subrahmanya},
title = {Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {35},
pages = {34023--34064},
doi = {10.1039/d6ra03227c}
}
EUVIMED